4Life Transfer Factor Approved by the Health Ministry of Russia for use in Hospitals

and Clinics!
4Life® Transfer Factor™ Approved By the Health Ministry of Russia for use in
Hospitals and Clinics!

First Ever Dietary Supplement to be Approved for Use by Doctors and Hospitals in
Russia
SANDY, UT (October 1, 2004) - In an unprecedented announcement in the history of
network marketing, 4Life announced today that 4Life Transfer Factor products as immune
modulators have been approved for use in hospitals and clinics in the Russian Federation.
The results of ten separate clinical trials and two experimental studies on 4Life Transfer
Factor products were combined in a Methodological Document that was approved by the
Ministry of Health, which now allows doctors to recommend 4Life Transfer Factor Classic
and 4Life Transfer Factor Plus® products to their patients.

First Dietary Supplement Approved for Use by Doctors and Hospitals in Russia
Commenting on this remarkable achievement, David Lisonbee, CEO of 4Life stated, “To my
knowledge, this is the first time in the history of this industry that a network marketing
company or any other dietary supplement company has had one of its dietary supplements
approved for use in hospitals in Russia. The Russian Ministry of Health is the equivalent of
the Food and Drug Administration in the United States. Doctors and scientists from Russia
have been working jointly with scientists from 4Life for several years to arrive at this
accomplishment. This approval establishes a new roll of dietary supplements in the Russian
health care system.

Remarkable Response from Russian Academy of Medical Sciences

In another sector of research of 4Life Transfer Factor, Dr. Kisielevsky of the Russian
Academy of Medical Sciences stated, “The 4Life sample [Transfer Factor Advanced Formula]
activated NK (natural killer) cell activity more than the Interleukin-2 (IL2) drug we used as the
standard.” This discovery has attracted the attention of The International Scientific and
Technical Center (ISTC) of Russia.

Scientists from Several Countries Join Forces for Additional Clinical Studies of Transfer
Factor

The ISTC of Russia is a member of a joint international project with other health agencies of
Japan, Europe and the US. The objective of the international project is to combine efforts in
finding improved immunotherapies. Following the discoveries from the NK cell testing, the
scientists of 4Life have been invited to join the project. 4Life Transfer Factor as an immune
modulator will be further researched in this international forum. The cost of the studies will
be paid by the ISTC.
Worldwide Ramification
Speaking of this benchmark achievement, Dr. Calvin McCausland, VP of Research of 4Life,
and Dr. Emma Oganova, 4Life/Eurasia President, jointly expressed that because of the
acceptance by such a reputable organization and doctors from Russia and other major
countries, 4Life Transfer Factor will gain wider acceptance in the professional and private
sectors as a superior immune system enhancing product. The worldwide ramifications to this
acceptance are just beginning.

4Life Research is the World’s foremost leader in the development, production and
distribution of natural immune support products and was recently recognized by Inc.
magazine as the fifteenth fastest growing privately-held company in America.

4Life Transfer Factor® Products in 2013 Physicians’ Desk Reference

Salt Lake City, Utah (January 8, 2013) 4Life executives are pleased to announce that 4Life
Transfer Factor® products are listed in the 2013 Physician’s Desk Reference (PDR).

“We are thrilled to be part of this prestigious and valuable publication. This is the ninth year
that 4Life products have been listed,” stated Director of Product Development Chad
Renshaw. “The PDR is among the most substantiated resources in the medical community
and is distributed to 500,000 health professionals across the United States. Having 4Life
products included provides distributors with unrivaled credibility when presenting our
products to customers.”

The 2013 edition of the PDR provides in-depth product information about 4Life Transfer
Factor® and 4Life® Transfer Factor Plus® Tri-Factor® Formulas. In addition, the publication
offers a technical description of the product line and synopses on several scientific studies.
With nine worldwide patents and dozens more pending, an in-house Research and
Development team, the scientific input of the Health Sciences Advisory Board, and the
industry’s only immunological testing lab, 4Life’s commitment to Transfer Factor science is
well established.

Director of Health Information Systems Brent Vaughan: “This professional listing is an

invaluable asset for 4Life distributors. The publication strengthens the field’s position as
exclusive leaders in the distribution of 4Life Transfer Factor products.”
4Life has offices on five continents to serve a global network of independent distributors
through science, success, and service.

4Life Global Growth Continues

Salt Lake City, Utah (January 13, 2011) 4Life® President Steve Tew recently announced that
December 2010 was the company’s best sales month in company history. Sales for the
month were up 19% from the previous year with annual 2010 worldwide sales up over 20%.
Steve Tew: “4Life’s global growth throughout 2010 has been phenomenal. Our worldwide
markets continue to post record sales as a result of the strong dedication of our distributors,
who each recognize the value of 4Life Transfer Factor® and the business opportunity for
success.”
Since the company’s launch in 1998, 4Life has established itself as a world leader in direct
sales. In 2003, Inc. 500 recognized 4Life as the 15th fastest growing privately-held company
in the United States. In 2010 and 2011, Direct Selling News named 4Life among the top 100
Global Direct Selling Companies.

Five Top-Performing Countries & Regions

United States * Malaysia * Eurasia Mexico * Colombia

Highest Sales Growth Rate Countries

Thailand–57% * Korea–48.5% * Peru–48%
Philippines–43% * Eurasia–36%
David Lisonbee, 4Life Founder and CEO from Milan, Italy: “4Life distributors have made
2010 the company’s best year to date. Our corporate team is committed to providing our
distributors with the support they need to continue this success. We look forward to ongoing
global growth in 2011 and beyond.”

4Life has offices on five continents to service a global network of independent distributors
through science, success, and service.

4Life Receives New Patent

Salt Lake City, Utah (January 3, 2011) 4Life Research™ announced today that the United
States Patent & Trademark Office (USPTO) has awarded the company a composition patent
that protects the 4Life Transfer Factor® Cardio formula until 2025. This is the company's
sixth worldwide patent. 4Life has numerous international patents and dozens of patent
applications pending.

4Life’s progressive science and pursuit of patent protection strengthens the business
opportunity for 4Life distributors with the exclusive right to market 4Life Transfer Factor®
products. 4Life President Steve Tew: “We invest a great deal of resources into patent
protection on behalf of our distributors because we know that the opportunity they share
must accompany the kind of exclusivity, credibility, and longevity that patents exist to
provide.”

4Life's commitment to patents includes an emphasis on research and development to

generate formulas, compositions, and processes that are patentable. While 4Life's legal
team concentrates on patent acquisition, the International Product Registration department
focuses on registrations around the world to support distributor growth now and in the future.
In 2010, 4Life completed 101 product registrations in 30 countries.

4Life Founder and CEO David Lisonbee: "Patent protection is just one way that we work to
empower 4Life distributors with exclusivity and credibility in the marketplace. 4Life patents
provide our distributors with security for decades to come.

4Life has offices on five continents to serve a global network of independent distributors
through science, success, and service.

4Life Announces Athletic Product Endorsement

Mark Todd & his horse, Gandalf
Salt Lake City, Utah (June 19, 2008) 4Life Research™ announced today that Mark Todd,
famed New Zealand equestrian, will publicly endorse 4Life Products.
Todd was voted Rider of the 20th century by the International Equestrian Federation. He is a
four-time Olympic medalist, including two gold medals. He primarily competes in eventing,
which includes dressage, cross-country, and show jumping. In 1984 and 1988, he was the
first rider to win successive individual three-day-event Olympic gold medals in 60 years. He
won the prestigious Badminton Horse Trials on three occasions and the Burghley three-day
trials five times.

He retired from eventing following the 2000 Sydney Olympics, but decided to make a return
for the 2008 Beijing Olympics. In May 2008 he qualified for the 2008 Olympics at the three-
day event in Samur, France.

“I am 52 years old and competing in my fifth Olympics,” remarked Todd. “I use 4Life Transfer
Factor Plus® to help keep me at the top of my game. It provides the well-being and healthy
energy support I need to continue at top-level competition.”

“I’m very excited to have Mark Todd endorse 4Life Products,” commented Vice President,
International Jason Norton. “As an accomplished equestrian in New Zealand, his
endorsement speaks volumes to distributors and new recruits about the quality of our
products. This is exciting news for
4Life markets around the world.”

“I’m thrilled about Todd’s endorsement agreement,” remarked Managing Director of 4Life
Australia and New Zealand Ben Riley. “He understands the importance that nutrition and
supplementation play in maintaining wellness, and uses 4Life Products to help him perform
his best.”

4Life, the leader in the development, production, and distribution of Transfer Factor support
products, continues to post growth in more than 40 countries around the world.

4Life Transfer Factor® Products Approved for Use by Olympic Athletes

Salt Lake City, Utah (December 4, 2007) As first reported by 4Life Chief Scientific Officer
Calvin McCausland, Ph.D., in Direct Selling News, 4Life received documentation from the
Federal Anti-Doping Center in Moscow, Russia, that admits 4Life Transfer Factor for use by
Olympians in practice, training, and competition. Approval was obtained after volunteers
consumed 4Life Transfer Factor products and their bodily fluids were analyzed in
accordance with doping control procedures that employ modern methods of gas
chromatography and mass-spectrometry in compliance with the World Anti-Doping Agency in
Montreal, Canada.
“We are very pleased by this approval,” commented President of Eurasia Emma Oganova,
M.D., Ph.D. “4Life Transfer Factor continues to define the cutting-edge of immune system
science.”

4Life Founder and Chief Executive Officer David Lisonbee launched 4Life Research in 1998
with a commitment to the highest scientific standards. Ongoing research and development of
Transfer Factor technology has fueled 4Life’s constant growth and maximized every
distributor’s ability to grow a successful independent business.

“Arguably, this kind of marketplace positioning and high level product messaging simply isn’t
possible without the involvement of a professional research and development team,” added
McCausland.

“I am pleased with our continued evolution in the supplement industry,” stated Executive
Vice President Bruce Redd. “The quality work of our Research and Development department
is certain to keep 4Life on the leading edge of science and success for years to come.”

4Life, the leader in the development, production, and distribution of Transfer Factor support
products, continues to post growth in more than 40 countries around the world.
4Life Research Announces New Discovery - NanoFractions

September 21, (Salt Lake City, Utah) 4Life Research™, the world leader in Transfer
Factor science and immune system support development, announced today the discovery of
immune activity in a weight range of molecules significantly smaller than transfer factors.

Transfer factors are molecules in a weight class between 3,500 - 12,000 daltons that help
the immune system recognize, respond to, and remember outside threats. Although
scientists have known that smaller molecules than transfer factors existed within cow
colostrum, their significance in terms of immune activity has been unknown until now. In
2005, 4Life Chief Executive Officer David Lisonbee and the Research and Development
department began studying these low weight molecules. After two years of research, 4Life
clinical findings now indicate that molecules in a weight range between 250 — 3,000 daltons
play important regulatory roles in the immune system. 4Life extracted and concentrated
these nanofraction molecules from cow colostrum for their proprietary NanoFactor™ extract,
combining NanoFactor with their exclusive Transfer Factor E-XF™ extract of transfer factors
from cow colostrum and chicken egg yolks to produce 4Life Transfer Factor® Tri-Factor™
Formula, the most comprehensive approach to immune system support available today. "I
don't know of another company in our category," said 4Life Chief Scientific Officer Calvin
McCausland, Ph.D. "In 2004, we were the first company to combine transfer factors from
cow colostrum and chicken egg yolks. In 2005, we introduced RioVida®, the world's only
transfer factor beverage. Now, the discovery of new immune activity in nanofractions. When
it comes to scientific innovation, there's simply no comparison to 4Life." 4Life Transfer Factor,
Transfer Factor Plus®, and RioVida are now fortified with the new Tri-Factor Formula. "We're
taking Tri-Factor Formula to the world because no other product represents such a unique
and indispensable opportunity for a quality life," remarked 4Life President Steve Tew.David
Lisonbee: "At the end of the day, our distributors can rest assured that 4Life will stay a good
pace ahead of the curve in the areas of science, service, and success." 4Life, global leader
in the development, production, and distribution of Transfer Factor immune support products,
continues to post growth in more than 40 countries around the world.